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Desynchronization of diurnal rhythms in
bipolar disorder and borderline personality
disorder
Oliver Carr 1, Kate E. A. Saunders2,3, Amy C. Bilderbeck2,3, Athanasios Tsanas4,5, Niclas Palmius1, John R. Geddes2,
Russell Foster 6, Maarten De Vos1,6 and Guy M. Goodwin2,6
Abstract
It has long been proposed that diurnal rhythms are disturbed in bipolar disorder (BD). Such changes are obvious in
episodes of mania or depression. However, detailed study of patients between episodes has been rare and
comparison with other psychiatric disorders rarer still. Our hypothesis was that evidence for desynchronization of
diurnal rhythms would be evident in BD and that we could test the speciﬁcity of any effect by studying borderline
personality disorder (BPD). Individuals with BD (n= 36), BPD (n= 22) and healthy volunteers (HC, n= 25) wore a
portable heart rate and actigraphy device and used a smart-phone to record self-assessed mood scores 10 times
per day for 1 week. Average diurnal patterns of heart rate (HR), activity and sleep were compared within and across
groups. Desynchronization in the phase of diurnal rhythms of HR compared with activity were found in BPD (+3 h)
and BD (+1 h), but not in HC. A clear diurnal pattern for positive mood was found in all subject groups. The coherence
between negative and irritable mood and HR showed a four-cycle per day component in BD and BPD, which was not
present in HC. The ﬁndings highlight marked de-synchronisation of measured diurnal function in both BD but
particularly BPD and suggest an increased association with negative and irritable mood at ultradian frequencies. These
ﬁndings enhance our understanding of the underlying physiological changes associated with BPD and BD, and
suggest objective markers for monitoring and potential treatment targets. Improved mood stabilisation is a
translational objective for management of both patient groups.
Introduction
Human biology is circadian. The central oscillator or
clock in the suprachiasmatic nucleus of the brain has a
harmonic cycle of about 24 h and a sleep homeostat
overlays the clock. The sleep/wake cycle is the most
obvious expression of this physiology. Sleep is commonly
disturbed in psychiatric disorder. In the case of bipolar
disorder (BD), sleep deprivation leads to mood elevation
and mania1. This striking linkage is often used to claim
that circadian rhythms are disturbed in mood disorders2,3.
However, a sleep effect does not automatically imply
involvement of the circadian clock although sleep
abnormalities appear to be associated with some other
diurnal measures in bipolar disorder4. The relationship
between mood and diurnal function is of particular
interest when patients are apparently well, because
abnormal sensitivity to different aspects of sleep or the
circadian cycle might explain why patients with BD show
persistent mood instability in euthymia or have the
potential to decompensate into mania or depression5.
Accordingly, it is when patients are well and between
episodes that interventions to stabilise mood must be
developed and deployed.
We have previously suggested that mood instability may
be an important target for testing the potential efﬁcacy of
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possible mood stabilising treatments6. However, experi-
mental investigation of mood instability has been very
limited and largely conﬁned to the study of symptom
patterns. A link with possible disturbances of diurnal
physiology has not hitherto been demonstrated. However,
diurnal changes in daytime activity have been found to
differentiate BD participants and controls7. Wearable
devices which record quantitative behavioural and phy-
siological signals that enable collection of passive data
streams. Such devices offer the potential to analyse
objective correlates of mood symptoms.
In the present study patients with either BD or bor-
derline personality (BPD), together with healthy volun-
teers (HC), were studied in an observational protocol,
which yielded intensive data over several days. As indi-
cated, BD has long been of interest from a circadian
perspective. BPD resembles BD in that patients experi-
ence mood instability, but this variability of mood is
greater6. Descriptions of sleep difﬁculties in BPD refer
quite non-speciﬁcally to insomnia8. The BPD group were
a relevant control group because the diagnoses are
sometimes confused even though heritability and the
clinical course are different from BD. Our hypothesis was
that disruption of the synchrony of diurnal physiology
would be disturbed in BD and we would test whether the
effect was speciﬁc to the BD phenotype, as is often
claimed or assumed, by comparison with BPD. Our
methodology was to observe the diurnal variation in total
activity and relate this to vertical acceleration (an
approximation of sleep per se) and to heart rate (HR). We
have also looked at diurnal or ultradian correlations
between these objective measures of physiology and
subjective mood sampled intensively up to ten times daily
over the same time interval.
Patients were studied in the mood state that was most
normal for them. For BD, they were not syndromally
depressed or hypomanic. However, they were sympto-
matic as the majority of BD patients are most of the time.
BPD patients were not in a crisis but they were sympto-
matic, as they are almost all the time. These states are of
particular interest because the challenge for the long term
is the risk of relapse (BD) or crisis (BPD) and the trans-
lational need is to innovate new mood stabilising
interventions.
Methods
A total of 129 participants were recruited (54 BD, 31
BPD and 44 healthy controls (HC)) as part of the Auto-
mated Monitoring of Symptom Severity (AMoSS) study at
the University of Oxford9, with participant information
summarised in the supplementary information. The study
was approved by the NRES Committee East of England—
Norfolk (13/EE/0288). All participants gave written
informed consent. The AMoSS study collected
behavioural data from participants9, in addition to self-
reported mood scores using a smartphone app (Mood
Zoom or MZ), and self-reported clinically validated
questionnaires to capture psychiatric symptoms6,10. Par-
ticipants diagnosed with BD or BPD and healthy controls
were recruited for the study through previous studies,
local advertising and word-of-mouth. All the participants
were screened by an experienced psychiatrist (KEAS)
using the structured clinical interview for DSM IV and the
BPD module of the international personality disorders
examination. The HC participants were excluded if they
had any history of depression or screened positive for an
axis 1 disorder or BPD. They agreed initially for 3 month
period of recording, with the option of continuing parti-
cipating in the study and providing mood recordings
beyond the ﬁrst 3 months. Data collection started in
March 2014 and the data analysed here were collected up
until February 2016. The self reported MZ mood ratings
and the clinical ratings have been described already in
relation to their variability across the study groups6,9,10,
but not in relation to the diurnal pattern to be illustrated
here.
For 1 week during the study, the participants underwent
‘high intensity’ monitoring, during which multiple signals
were recorded from a Proteus patch (www.proteus.com),
stuck to the torso of participants. The patch was not
removed during the whole ‘high intensity’ week and
recorded HR and acceleration in three directions at one
sample per minute. The patch recorded HR and accel-
eration in three directions, with ‘estimated sleep period’
measured from vertical acceleration which determines
when participants are lying down (see ref. 11).
Mood data were collected through the MZ smart-phone
application, which prompted participants to provide their
mood 10 times evenly spaced throughout each day. The
prompts typically started at 1000 hours and ﬁnished at
2000 hours, thus on average mood characteristics were
self-reported every hour. Participants rated six mood
items in the smart-phone application: anxious, elated, sad,
angry, irritable and energetic on a seven point Likert scale
from zero, corresponding to ‘not at all’, to six, corre-
sponding to ‘very much’. For further details on MZ see
Tsanas et al.6.
The HR data obtained from the Proteus patch gave an
average over 5 min intervals; it did not permit measure-
ment of conventional beat-to-beat HR variability. How-
ever, the data allowed for long term analysis of diurnal
patterns in physiological and behavioural measures. The
acceleration signals are recorded in vertical, horizontal
and forward directions, with a sampling frequency of
0.017 Hz (once per minute).
The data obtained from the Proteus patch, which is
shown in Fig. 1, allows broad band analysis of both phy-
siological and behavioural measures of diurnal rhythm.
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However, in practice, viable recordings from each parti-
cipant were of variable durations, ranging from 1 day to
over 8 days. For time domain analysis of average diurnal
rhythms, data were processed from: 38 BD participants
(13 male and 25 female with a mean age of 39.7 ± 12.6
years and a mean BMI of 27.2 ± 5.1 kg/m2), 22 BPD par-
ticipants (2 male and 20 female with a mean age of 34.4 ±
10.9 years and a mean BMI of 27.5 ± 5.9 kg/m2), and 27
HC participants (6 male and 21 female with a mean age of
40.9 ± 13.9 years and a mean BMI of 24.8 ± 4.0 kg/m2).
Data from other participants was not used only if their
acceleration and HR signals were missing or of poor
quality. This was due to a number of reasons: the devices
not recording any data, the patch falling off or being
removed before 4 days of recording and devices recording
noisy data with large numbers or artefacts. Details on the
non-participants are provided in Table 1.
For frequency domain analysis, only participants who
had 4 or more days of recording provided a good repre-
sentation of diurnal variability. For these participants, the
ﬁrst 4 days of the recording were selected to standardise
the analysis. Thus, we processed data from: 18 BD parti-
cipants (4 male and 14 female with a mean age of 40.9 ±
11.4 years and a mean BMI of 26.1 ± 3.9 kg/m2), 14 BPD
participants (2 male and 12 female with a mean age of
34.3 ± 10.2 years and a mean BMI of 25.9 ± 5.1 kg/m2) and
20 HC participants (4 male and 16 female with a mean age
of 43.4 ± 14.6 years and a mean BMI of 24.6 ± 4.2 kg/m2).
Mood zoom data
Principal component analysis was applied to the pooled
MZ data from all participants in the study across all
groups, with the ﬁrst three components used to quantify
the mood of participants6. The ﬁrst principal component
is a measure of negative mood, the second is a measure of
positive mood and the third principal component is a
measure of irritability10.
The average diurnal rhythms of mood were found
through linear interpolation of the mood entries to an
evenly spaced sample frequency of 0.017 Hz (or one
sample per minute) and the average was taken across all
available 24 h periods.
Extracting diurnal rhythms
Figure 1 shows the behavioural and physiological data
from a randomly chosen single subject (total acceleration,
Fig. 1 An example of data recorded from the Proteus patch for one participant. a total acceleration, b integrated total acceleration with daily
sinusoid ﬁts, c vertical acceleration, d integrated vertical acceleration with daily sinusoid ﬁts, and e HR with daily sinusoid ﬁts
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vertical acceleration and HR) to demonstrate diurnal
rhythms. Acceleration data were integrated to give a
smooth measure of movement (the integration was per-
formed by removing the mean and then integrating an
overlapping window of 6 h which is shifted by one data
point along the entire signal). There is an obvious ﬁrst
harmonic at around 1 cycle/24 h, corresponding to the
diurnal period.
The HR data were pre-processed to remove artefacts in
the signal. The value of HR at each recorded instance was
compared to the value recorded at the preceding time
instance: if the value was over 150% or under 50% of the
previous value the value at the current time was set to the
mean of the preceding and succeeding values, with a
mean of 0.9% ± 1.1% of the data being adjusted for each
participant. An indicative example of the recorded data is
presented in Fig. 1. The HR signals again exhibit natural
sinusoidal behaviour as can be seen in Fig. 1e, like the
integrated acceleration signals in Fig. 1b, d.
Diurnal rhythms were quantiﬁed by ﬁtting a sine wave
to a 24 h signal by quantifying the phase, average value
and amplitude, known as the Cosinor method12–14. Here,
this analysis has been extended to longer term signals over
a number of days through ﬁtting of sine waves to each
separate day of the signal for integrated total acceleration,
integrated vertical acceleration and HR, before ﬁnding the
average of the daily sinusoids, shown in Fig. 1b, d, e (see
ref. 11). Detailed methods of ﬁtting sinusoids are shown in
the supplementary materials.
Coherence analysis
The magnitude-squared coherence was calculated for
the nine pairs of acceleration and HR recordings with the
three principal components of mood. Coherence is used
to determine the linear relationship between two signals
through their frequency spectrum, or ﬁnding the corre-
lation in the frequency domain. The magnitude squared
coherence is calculated as:
Cxy fð Þ ¼ jGxy fð Þj
2
Gxxðf ÞGyyðf Þ
ð1Þ
Table 1 Median and interquartile range of the average phases, MESORs and amplitudes of the daily sinusoid ﬁts for
each of the participant groups, the difference between phases of each modality, and statistical signiﬁcance pairwise
comparisons across the three groups (BD n= 36, BPD n= 22 and HC n= 25) using the Wilcoxon statistical hypothesis test
Within group phase differences tested against zero mean
BD BPD HC BD (FDR) BPD (FDR) HC (FDR)
HR-ACT (mean ± std) 0.72 ± 4.17 3.11 ± 3.08 0.46 ± 4.06 0.017 <0.001 0.246
HR-SLP (mean ± std) 0.56 ± 3.41 0.99 ± 1.66 −0.83 ± 2.11 0.006 0.006 0.051
ACT-SLP (mean ± std) −0.16 ± 2.90 −2.12 ± 3.21 −1.29 ± 2.87 0.180 0.005 0.004
Group differences in phase, MESOR and amplitude
BD BPD HC BD vs BPD (FDR) BD vs HC (FDR) BPD vs HC (FDR)
Activity
Phase (mean ± std) 14.09 ± 2.83 12.34 ± 3.57 12.82 ± 3.31 0.253 0.410 0.403
MESOR (mean ± std) 0.014 ± 0.004 0.013 ± 0.003 0.014 ± 0.004 0.276 0.418 0.418
Amplitude (mean ± std) 0.0033 ± 0.0021 0.0026 ± 0.0014 0.0027 ± 0.0013 0.294 0.401 0.380
Sleep
Phase (mean ± std) 14.25 ± 1.68 14.46 ± 2.07 14.12 ± 1.31 0.398 0.483 0.391
MESOR (mean ± std) 0.35 ± 0.08 0.34 ± 0.07 0.36 ± 0.07 0.477 0.411 0.385
Amplitude (mean ± std) 0.11 ± 0.02 0.11 ± 0.03 0.11 ± 0.02 0.325 0.444 0.276
Heart rate
Phase (mean ± std) 14.81 ± 3.21 15.45 ± 2.07 13.28 ± 2.37 0.384 0.086 0.051
MESOR (mean ± std) 75.24 ± 7.08 77.65 ± 5.69 74.48 ± 2.62 0.251 0.425 0.275
Amplitude (mean ± std) 8.10 ± 2.54 8.67 ± 3.45 7.41 ± 2.62 0.369 0.300 0.289
To test phase differences against zero mean within groups, a Mann–Whitney test was used at 5% signiﬁcance level. Correction for multiple testing was performed
using the false discovery rate (FDR)
Statistically signiﬁcant differences at the p= 0.05 level appear in bold. avPhase, avMESOR and avAmplitude denote the mean of the phases, MESORs and amplitudes
of the daily sinusoid ﬁts. The units of all phase measures are shown in hours
Carr et al. Translational Psychiatry  (2018) 8:79 Page 4 of 9
where Gxy(f) represents the cross-spectral density between
signals x and y, and Gxx(f) and Gyy(f) represent the auto-
spectral density of signals x and y, respectively.
A coherence value of one indicates an ideal linear sys-
tem at a certain frequency, whereas zero indicates the two
signals are not linearly related. A value between zero and
one indicates the fraction of the output signal which is
produced by the input signal at each given frequency. The
coherence analysis was only performed on participants
with over 4 days of recorded data in order to express the
relationship between the diurnal variations in the signal.
Coherence was calculated on the entire length of the raw
signals, with a minimum of 1 day up to 8 days, where the
signals were linearly interpolated to obtain values at 1 min
resolution.
Statistical tests
The average amplitude, phase, midline estimating
statistic of rhythm (MESOR) (or average measure) and
phase differences of the daily sinusoids of acceleration,
vertical acceleration and HR were computed for each
participant14. Within group phase difference between
acceleration, vertical acceleration and HR were tested
against zero mean using a Mann–Whitney at a 5% sig-
niﬁcance level. The two-tailed Wilcoxon signed rank
test was used to compare the average amplitude, phase
and MESOR pairwise across groups, multiple testing
was corrected using the positive false discovery rate
(FDR) with a conventional signiﬁcance level of 5%, as
deﬁned in Storey15.
The coherence between the measured signals and
participant mood was calculated at each frequency for
each subject group. The coherences were combined to
create a signals, which were tested for statistically sig-
niﬁcant differences between the groups. At each fre-
quency, pairwise tests were performed between the
groups using the two-tailed Wilcoxon rank sum test
with a 5% signiﬁcance level. Permutation testing was
Fig. 2 Average sinusoids of sleep, HR and activity shown for two days for each subject. Statistically signiﬁcant differences (p < 0.05) between
the phase of each pair of sinusoids, testing if the mean differs from zero, are marked with an asterisk. A signiﬁcant difference suggests there is a phase
lag between the two measures
Fig. 3 Diurnal patterns (over two days) for each subject group of the average score for the ﬁrst three principal components of MZ, a negative, b
positive and c irritable, repeated over a 48 h period. Solid line represents the mean score, with the dashed period representing the times where no
MZ recordings are made. Shaded regions show the standard deviation divided by the square root of group size
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applied when calculating p-values for the coherence in
order to correct for the multiple statistical comparisons.
Permutation testing was carried out at each frequency,
where the labels were randomly assigned to the parti-
cipants (keeping the same distribution as the true labels)
1000 times, from which the corrected p-value is
calculated.
Results
Diurnal rhythms in objective measures of physiology
The signal of vertical acceleration will be referred to as
measuring ‘sleep’, recognising that it is an imperfect
estimate of just one element of sleep.
The average ﬁrst harmonic sinusoidal ﬁts for the diurnal
measures are shown in Fig. 2 for each subject group. For
the HC, data largely overlap, with a small phase lag (1.5 h)
between activity and sleep, as would be expected: HR is in
phase with activity. In BD, the difference between activity
and sleep was absent; instead there was signiﬁcant phase
delays in the HR signal of about 1 h compared with sleep
and activity. For BPD there was a 2 h phase lag between
activity and sleep and almost 3 h delay between peak
activity and peak HR. In addition the average HR level in
BPD was substantially higher then HC, with BD inter-
mediate, even with similar activity levels across all groups.
These statistical differences between groups and within
groups are quantiﬁed in Table 1. Also in Table 1, the
average phase, MESOR and amplitude is compared for
activity, sleep and HR across groups; the average values
are broadly similar across groups, with the exception of
the HR MESOR which was elevated in BPD compared
with HC.
Diurnal rhythms in subjective measures of mood
Figure 3 shows the mean diurnal patterns of the ﬁrst
three components of MZ for each subject group (shaded
region represents±standard error). Negative mood was
clearly higher in the patient groups than in controls (Fig.
2a, BPD>BD>HC); cyclicity was not markedly diurnal in
any group, although higher ultradian frequencies
appeared to occur in BPD. For positive mood, lower
frequency quasi-diurnal changes were evident for all
groups. Finally, for irritable mood there appeared to be
higher frequency ultradian components for all three
groups along with different mean levels as for negative
mood.
Effects of medication
Many BD and BPD participants were taking medication
which included lithium, antipsychotics, antidepressants,
anticonvulsants, anxiolytics and hypnotics. There was no
consistent pattern of effect of any drug on any of the
measures (see supplementary data).
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The correlation between objective and subjective diurnal
measures
As there were either or both diurnal and ultradian
variations in mood, especially in the patient groups, an
exploratory analysis of the coherence between subjective
mood and objective measures of physiology was made
across relevant frequencies.
At low frequencies (around 1 cycle per 24 h), mood
measures were similarly correlated for all three groups.
Negative mood and irritable mood was quite weakly
associated with physiology, whereas there was generally a
greater signal in the association between positive mood
and total activity, sleep signal and HR (see Fig. 4),
At higher frequencies (around 4 cycles/24 h), differ-
ences were apparent between groups. Negative mood was
more highly correlated with activity in both BD and BPD
compared with HC. Irritable mood was more highly
correlated with HR in both BD and BPD compared to HC.
Discussion
The total acceleration, vertical acceleration (sleep) and
HR signals were strongly diurnal, as expected. HC showed
a 1.5 h lag between activity and sleep and HR was in phase
with activity. BD showed no lag between activity and sleep
but a 1 h phase delay in the HR signal compared with both
the other diurnal measures. For BPD there was a 2 h delay
between activity and sleep and almost 3 h between activity
and HR. The average HR in BPD and BD was higher than
HC, but may be explained by antidepressant medication.
Negative mood and irritability tended to be correlated
with higher frequency components of mood in BD and
BPD (at a 5–6 h period) rather than the diurnal cycle.
Positive mood correlated with activity and other diurnal
measures in all groups. Thus, there appears to be sig-
niﬁcant de-synchronization between different measures of
physiology in BPD and to a lesser extent BD, notably
between HR and activity, which are synchronised in HC.
The ﬁndings suggest that there is an important link
between mood and cardiovascular function in BD but
particularly in BPD. Both conditions are associated with
early cardiovascular mortality and our ﬁndings suggest
that enhanced mood regulation may be an important
factor in reducing cardiovascular risk.
The abnormalities in BD were modest in contrast with
the widely held view that BD is, in some quite funda-
mental sense, a disorder of diurnal function. In fact, the
strongest evidence has hitherto related to variability in
diurnal function rather than formal evidence for phase
changes or de-synchronization. Thus actigraphy studies
have shown less stable and more variable diurnal activity
in BD even in euthymia16–19, with additional disruptions
to sleep patterns20. In the present study, there was 1 h
phase delay for HR in relation to activity, and only trend
effects on the level of activity. Increased levels of
nocturnal activity have been described in unmedicated
young people with hypomanic experience21. The nor-
mality described here may in part reﬂect the impact of
drug treatment. However, it is difﬁcult to argue without
measurement of melatonin or other diurnal variables that
diurnal rhythm per se remains a problem or a potential
target for management in such patients. Variability in day
to day in sleep may be a different matter. A separate
analysis has suggested that such variability correlates with
mood instability: it is particularly relevant in BD for the
sleep cycle and for BPD in the sleep and HR cycles11.
BPD is not usually described as being associated with
diurnal disturbance, so the effects described here are of
great potential interest and clinical importance.
Abnormalities of the sleep wake cycle have been described
before in patient samples including BPD. Over 20 years
ago, a sample of 50 patients selected on the basis of
showing delayed sleep phase (43 patients) or free running
disorder (7 patients), having consulted for a sleep pro-
blem, were described also to show evidence of personality
disorder or, at least, psychopathology. There was no
particular emphasis on borderline traits and hence the
results were highly non-speciﬁc. Much more recently, a
study in adolescents suggested increased social jetlag in
BPD who slept an hour longer on average than matched
controls. This is again compatible with signiﬁcant delayed
sleep phase22. The delay in estimated sleep phase in BPD
implies increased sleep onset latency. Clariﬁcation of the
prevalence of circadian rhythm sleep disorders (CRSD) in
BPD merits further study. It is striking but perhaps not
surprising that no emphasis is placed on possible CRSD in
the contemporary management of BPD. CRSD has been
studied in small populations23, but not systematically in
large numbers of patients, with phototherapy or drugs like
melatonin or agomelatine to phase advance (and so reset)
the diurnal cycle. Clinical experience suggests this is
highly effective23. In a pilot study of a small group of BPD
patients with variable sleep/wake proﬁles, some beneﬁt of
light therapy was observed over 3 weeks24. Previous sleep
investigations in BPD have used polysomnography, with a
view to comparing BPD with mood disorder. Thus, a
recent systematic review of the relevant literature high-
lighted the reduced sleep quality in BPD compared with
healthy samples and the overlap with reported abnorm-
alities in patients with mood disorder8. It correctly iden-
tiﬁed sleep disorder as a broadly neglected element of the
management in BPD.
Does mood have an important diurnal component?
Diurnal mood variation is an important feature of severe
depression25, but has received limited attention in studies
of euthymic BD and BPD patients. We have shown here
that diurnal rhythms of mood exist across participant
groups. The use of a simple smart-phone based
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questionnaire, allowed an uncomplicated method of
monitoring mood. Inspection of the average mood proﬁle
suggested that positive mood had a signiﬁcant diurnal
component: it was coherent with all three biological
measures of diurnal function at the 1 cycle/day frequency
in BD and HC groups. BPD showed a weaker relationship
with total activity at 1 cycle per day and some activity at a
6 h cycle most seen in HC and BD.
Negative and irritable mood were less coherent with the
1 cycle per day rhythm than positive mood in all parti-
cipant groups. Negative mood was weakly coherent with a
6 h cycle in BD for sleep and perhaps total activity and in
BPD with total activity. Irritable mood was weakly
coherent with the 6 h cycle for HR in BD and BPD. The
meaning of this 6 h cycle is uncertain, but appears to
capture some ampliﬁcation of mood effects in the evening
in the patient groups.
Limitations
We acknowledge that the cohort in the study is rela-
tively small due to the technical limits of the devices used
to record data. Accordingly improved devices will provide
future opportunities to replicate and extend the present
approach. The participant sample had to be very co-
operative in wearing the devices and recording subjective
data, so are a selected group in that sense.
The choice of appropriate controls in case control stu-
dies is always challenging, because there is a risk of
recruiting super healthy individuals unrepresentative of
the general population. The present study is strengthened
by having two clinical groups whose diurnal physiology
show differences from each other and by matching for
demographic factors as far as possible including weight.
We did not correct for weekdays and weekend record-
ings, which will have added to the variance of the
recordings, and perhaps reduced our capacity to detect
cross-sectional differences in the diurnal behaviour of the
groups. Consequently we have emphasised within group
desynchronization as our major ﬁnding. It is also possible
that environmental and behavioural differences existed
between the groups, such as timings and composition of
food, light exposure, social stress and other factors. These
may have found expression in the measures we could
make. Finally, most patients were medicated, but with
differences between the BD and BPD groups.
The diurnal rhythms of HR variability is a further
measure which may exhibit difference between partici-
pant groups. The duration of ECG recordings from the
participants in this study were not sufﬁcient for analysis of
diurnal rhythms of HR variability and the sampling fre-
quency of the HR recorded from the Proteus patch is too
low to measure diurnal patterns. Further work will focus
on calculating proxies for HR variability from the Proteus
patch data and methods for diurnal analysis.
These limitations have to be viewed from the perspec-
tive of our primary objective, which was to measure
diurnal features between episodes in BD (between crises
in BPD). Time between episodes represents an at risk
state to which the lived environment contributes, whether
on medication or not. The point of intensive subjective or
objective monitoring is to identify relevant differences
that may serve as a future focus for disease management.
Conclusions
The phase of diurnal variation in HR is delayed relative to
peak activity in BPD (almost 3 h) and BD (1 h), and for sleep
2 h in BPD and not in BD. There abnormalities represent
de-synchronization of the diurnal rhythm in HR in BPD and
also in BD. Correlations between negative and irritable
mood and HR were also increased in the patient groups
compared with HC. The ﬁndings suggest that regulation of
cardiac function is possibly more strongly linked with mood
regulation in BPD and BD than in HC. This is interesting in
view of the early cardiac mortality associated with both
conditions26. Diurnal function has been a neglected feature
of BPD, which merits as much if not more attention than
that accorded to BD. Improved measurement of physiolo-
gical variables offers important opportunities to reﬁne drug
and psychological interventions for hard to treat disorders
with marked mood instability.
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